disorders and are, therefore, increasingly considered in psychiatric diseases models and experimental therapeutic approaches. Moreover, numerous neuroimmunological diseases like autoimmune encephalitis or multiple

Kraemer A, Knapp S, Windheim M, Kotlyarov A, Menon MB & Gaestel M Cell Death Discov 9: 262 On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer Boudghene-Stambouli F, Soulez M, Ronkina N,

1411971 Grote-Koska D, Czajkowski S, Brand K. ( 2015 ). Performance of the New RapidFire System for Therapeutic Monitoring of Immunosuppressants. Ther. Drug. Monit. 37: 400-404. Grote-Koska D, Czajkowski S,

17102. Epub ahead of print. PMID: 35607817. Sörensen-Zender I, Rong S, Haller H, Schmitt R. The Therapeutic Potential of Zinc-Alpha2-Glycoprotein (AZGP1) in Fibrotic Kidney Disease. Int J Mol Sci. 2022 Jan

treatment - a systematic review and metaanalysis. Predictors of adverse events during and after therapeutic plasma exchange - a retrospective cohort study. Kontakt E-Mail schmidt.bernhard(at)mh-hannover

Institute of Health Sciences Fenja Laue Research Topic: Pan-genotypic neutralizing antibodies as a therapeutic option against Hepatitis E Virus Supervisor: Dr. Patrick Behrendt, Research Group Translational

November 2020. Jovana Markovic SERBIA Supervisor: Dr. Amar Deep Sharma, AG Cantz, OE 6817 Project: Therapeutic reprogramming for the treatment of chronic liver disesases. Final exam November 2021. Toni Luise

Schambach, Insitute of Experimental Haematology, Project: Development and validation of novel gene therapeutic approaches for correction of and protection from hearing loss Final exam June 2024 Dimyana Neufeldt

tumour microenvironment in hepatocellular carcinoma (HCC) (title: ‘Deciphering the function and therapeutic potential of innate lymphoid cells in the immune network of liver cancer to overcome resistance

magnetic stimulation (TMS)). We specialize in ECT given it is still one of the most effective therapeutic methods for the treatment of severe psychiatric conditions, such as DTD or pharmacotherapy-resistant [...] polymorphisms in cytochrome P450 enzymes (CYP) (and thus the failure to reach efficient, i.e., therapeutic drug levels) or the presence of pseudo-resistance (caused by inadequate drug intake or administration)